// App-Quantinova.ai

N22 : Audit into initial response to vedolizumab infusions for IBD

Researchers

Presenter

  • G Lloyd-Ford

Principal Investigators

  • M Gordon

Medical Centers

  • Aneurin Bevan University Health Board, Gastroenterology Ambulatory Unit, Newport, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved